Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 0.83 | -37.12% | -0.49 |
BOLT closed down 37.12 percent on Wednesday, May 15, 2024, on 18.65 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. The bears made the stock sink to a new 52-week low.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Fell Below 200 DMA | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| New 52 Week Closing Low | Bearish | 0.00% | |
| Stochastic Sell Signal | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% |
| Alert | Time |
|---|---|
| New 52 Week Low | about 22 hours ago |
| 2x Volume Pace | about 22 hours ago |
| 1.5x Volume Pace | about 22 hours ago |
| 3x Volume Pace | about 22 hours ago |
| 10x Volume Pace | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Products Tumor Cancer Immunotherapy Breast Cancer Immune Checkpoint Her2/Neu
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Products Tumor Cancer Immunotherapy Breast Cancer Immune Checkpoint Her2/Neu
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.03 |
| 52 Week Low | 0.8288 |
| Average Volume | 205,227 |
| 200-Day Moving Average | 1.10 |
| 50-Day Moving Average | 1.20 |
| 20-Day Moving Average | 1.13 |
| 10-Day Moving Average | 1.14 |
| Average True Range | 0.11 |
| RSI (14) | 31.97 |
| ADX | 20.91 |
| +DI | 17.88 |
| -DI | 37.08 |
| Chandelier Exit (Long, 3 ATRs) | 1.02 |
| Chandelier Exit (Short, 3 ATRs) | 1.15 |
| Upper Bollinger Bands | 1.33 |
| Lower Bollinger Band | 0.93 |
| Percent B (%b) | -0.26 |
| BandWidth | 35.08 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.02 |
| MACD Histogram | -0.0021 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.15 | ||||
| Resistance 3 (R3) | 1.18 | 1.11 | 1.09 | ||
| Resistance 2 (R2) | 1.11 | 1.03 | 1.09 | 1.08 | |
| Resistance 1 (R1) | 0.97 | 0.98 | 0.94 | 0.94 | 1.06 |
| Pivot Point | 0.90 | 0.90 | 0.88 | 0.88 | 0.90 |
| Support 1 (S1) | 0.76 | 0.82 | 0.72 | 0.72 | 0.60 |
| Support 2 (S2) | 0.69 | 0.77 | 0.67 | 0.58 | |
| Support 3 (S3) | 0.55 | 0.69 | 0.57 | ||
| Support 4 (S4) | 0.51 |
